Yuniza, Melani, Ratna Maila Dewi Anggraini, Yenny Dian Andayani. Efficacy and Safety of IL-5 Pathway-Targeting Biologics (Mepolizumab, Reslizumab, Benralizumab) in the Management of Hypereosinophilic Syndromes: A Systematic Review and Meta-Analysis. OAIJMR [Internet]. 2025Sep.2 [cited 2025Oct.13];5(5):593-12. Available from: https://www.hmpublisher.com/index.php/OAIJMR/article/view/780